Open Access
Consensus statement on the management of methicillin‐resistant S taphylococcus aureus nosocomial pneumonia in Asia
Author(s) -
Cao Bin,
Tan Thuan T.,
Poon Edwin,
Wang JannTay,
Kumar Suresh,
Liam Chong H. Kin,
Ahmed Kamal,
Moral Patrick,
Qiu Haibo,
Barez Marie Yvette,
Buntaran Latre,
Tampubolon Oloan E.,
Thamlikitkul Visanu
Publication year - 2015
Publication title -
the clinical respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.789
H-Index - 33
eISSN - 1752-699X
pISSN - 1752-6981
DOI - 10.1111/crj.12134
Subject(s) - medicine , pneumonia , context (archaeology) , intensive care medicine , methicillin resistant staphylococcus aureus , staphylococcus aureus , antimicrobial , microbiology and biotechnology , paleontology , genetics , bacteria , biology
Abstract Nosocomial pneumonia ( NP ; encompassing hospital‐acquired, health care‐associated and ventilator‐associated pneumonia) is one of the most common nosocomial infections and is associated with a mortality rate of 18.7%–40.8% in A sian countries. The burden of methicillin‐resistant S taphylococcus aureus ( MRSA ) infections in A sia is high, and approximately 13% of NP cases in A sia are caused by this pathogen. Evidence regarding optimal management of MRSA NP continues to evolve and is complicated by the fact that a significant proportion of cases are likely to be caused by isolates with reduced susceptibility to the main therapeutic agent, vancomycin. The A sian C onsensus T askforce on MRSA N osocomial P neumonia has developed this statement to provide consensus points on diagnosis, antimicrobial treatment and prevention strategies for MRSA NP in the A sian context, based on our review of A sian data, previous international guidelines and recent scientific evidence.